Filter
1731
Filtered Results: 1731
Text search:
WHO
South
East
Asia
Regional
Office
Featured
Recommendations
162
New Publications
450
Language
Document type
No document type
867
Studies & Reports
418
Guidelines
209
Manuals
92
Strategic & Response Plan
68
Training Material
20
Fact sheets
18
Situation Updates
17
Resource Platforms
12
Infographics
6
Brochures
2
Online Courses
2
Countries / Regions
Global
137
Myanmar / Burma
72
South–East Asia Region
71
India
69
Nepal
49
Asia
46
Bangladesh
32
Philippines
29
Western and Central Europe
27
Africa
25
Indonesia
24
Cambodia
20
Ethiopia
19
Uganda
16
Western Pacific Region
14
Thailand
13
Syria
13
Kenya
12
Middle East and North Africa
12
Pakistan
12
Tanzania
11
South Africa
10
Liberia
10
Ukraine
9
Afghanistan
9
Eastern Europe
9
Latin America and the Carribbean
8
Sri Lanka
8
Nigeria
7
Mozambique
7
West and Central Africa
7
East and Southern Africa
7
Yemen
7
Zambia
7
China
6
Rwanda
6
Laos
6
Haiti
6
Congo, Democratic Republic of
6
Russia
6
South Sudan
6
Timor Leste/ East Timor
5
Ghana
5
Sierra Leone
5
Malawi
5
Venezuela
5
Eastern Europe and Central Asia
5
Vietnam
5
Somalia
5
Iran
4
Zimbabwe
4
Moldova
4
Sudan
4
Central African Republic
4
North Macedonia
3
Turkey
3
Albania
3
Senegal
3
Burkina Faso
3
Jordan
3
Lebanon
3
Papua New Guinea
3
Brazil
3
Georgia
3
North Korea
2
Mexico
2
Kazakhstan
2
Malaysia
2
Guinea
2
Italy
2
USA
2
Belarus
2
Bosnia and Herzegovina
2
Palestine
2
Iraq
2
Madagascar
2
Eswatini/ Swaziland
2
Tajikistan
1
Colombia
1
Lesotho
1
Cameroon
1
Singapore
1
Kyrgyzstan
1
Niger
1
Peru
1
Vanuatu
1
Morocco
1
Mongolia
1
Qatar
1
Armenia
1
Croatia
1
Hungary
1
Saudi Arabia
1
Paraguay
1
Gabon
1
Turkmenistan
1
Japan
1
Belgium
1
Maldives
1
Tunisia
1
Argentina
1
Djibouti
1
Namibia
1
Egypt
1
Romania
1
Greece
1
Poland
1
Libya
1
Bhutan
1
Ecuador
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Countries
429
Clinical Guidelines
177
Key Resources
129
Public Health
120
Women & Child Health
114
Capacity Building
30
Pharmacy & Technologies
19
Toolboxes
HIV
180
Mental Health
139
COVID-19
118
Planetary Health
111
TB
79
NTDs
72
Rapid Response
71
Global Health Education
59
AMR
59
Disability
56
Refugee
45
Health Financing Toolbox
43
Natural Hazards
38
NCDs
37
Caregiver
36
Conflict
29
Malaria
27
Pharmacy
21
Zika
18
Ebola & Marburg
14
Cholera
11
Specific Hazards
8
Polio
7
Typhoon
3
Social Ethics
2
Safety and efficacy of long-acting injectable lenacapavir as pre-exposure prophylaxis to reduce the risk of HIV acquisition: a systematic review
recommended
New
Guidelines on lenacapavir for HIV prevention and testing strategies for long-acting injectable pre-exposure prophylaxis. Web Annex B
Pneumonia and diarrhoea account for 23% of under-five mortality and were responsible for an estimated 1.17 million deaths in children under five globally. Furthermore, pneumonia and diarrhoea were responsible for 18% of mortality in children 5–9 years of age, resulting in an estimated 86 000 preve...
The world is off track to make significant progress towards universal health coverage (UHC) (SDG target 3.8) by 2030 as improvements to health services coverage have stagnated since 2015, and the proportion of the population that faced catastrophic levels of out-of-pocket (OOP) health spending has i...
Only 8,730 asylum applications were registered in the EU+ in April, the lowest since at least 2008, and a massive 87% decrease from pre-COVID-19 levels in January and February.
The European Asylum Support Office (EASO) has released a special report which shows that the COVID-19 related travel restr...
Fact Sheet Global Atlas of medical devices
World Drug Report 2017
-5-
Accessed: 14.03.2019
Effective malaria prevention is threatened by widespread and increasing vector insecticide resistance. Failure to mitigate this threat will likely result in an increased burden of disease, with significant cost implications. This new framework provides support for the development of a national insec...
he statistics in this report are from the Emergency Events Database (EM-DAT) maintained by the Centre for Research on the Epidemiology of Disasters (CRED) which records disasters which have killed ten or more people; affected 100 or more people; resulted in a declared state of emergency; or a call f...
The 2018 global health financing report presents health spending data for all WHO Member States between 2000 and 2016 based on the SHA 2011 methodology. It shows a transformation trajectory for the global spending on health, with increasing domestic public funding and declining external financing. T...
Managing possible serious bacterial infection in young infants when referral is not feasible
recommended
It provides guidance on care for use in resource-limited settings or in settings where families with sick young infants do not accept or cannot access referral care, but can be managed in outpatient settings by an appropriately trained health worker. The guideline seeks to provide programmatic guida...
World Drug Report 2017
-1-
Accessed: 14.03.2019
Overcoming barriers in low- and middle-income countries
For the first time, this year’s report includes information on hepatitis C diagnostics. With a focus on selected countries with diverse HCV epidemics, the report provides updates on the various dimensions of access to HCV diagnostics and pha...
Opiates, cocaine, cannabis
World Drug Report 2017
-3-
Accessed: 14.03.2019
Amphetamine-type stimulants, new psychoactive substances
-4-
World Drug Report 2017
Accessed: 14.03.2019
This operational guidance provides a structured approach to support countries in sustaining priority services for HIV, viral hepatitis and sexually transmitted infections in the context of reduced external funding. The guidance is intended for national governments, public health programmes, communit...
This guide presents a basis for understanding how diarrhoeal diseases are currently influenced by climate and weather, and may be further exacerbated by climate change. It is a technical guide on how to conduct a Vulnerability & Adaptation assessment for diarrhoeal diseases and climate change, and p...
This publication describes the first WHO public-benefit Target Product Profiles (TPPs) for snakebite antivenoms. It focuses on antivenoms for treatment of snakebite envenoming in sub-Saharan Africa. Four TPPs are described in the document:
Broad spectrum Pan-African polyvalent antivenoms: products ...
